Cargando…

Diuretics in the management of chronic heart failure: when and how

Heart failure is an increasingly prevalent condition resulting in recurrent hospitalisations and significant mortality and morbidity. The management of heart failure has evolved, and multiple drugs have an established mortality benefit in heart failure with reduced ejection fraction. Although the fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Magdy, Joseph S, McVeigh, James, Indraratna, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722345/
https://www.ncbi.nlm.nih.gov/pubmed/36479331
http://dx.doi.org/10.18773/austprescr.2022.069
_version_ 1784843953246306304
author Magdy, Joseph S
McVeigh, James
Indraratna, Praveen
author_facet Magdy, Joseph S
McVeigh, James
Indraratna, Praveen
author_sort Magdy, Joseph S
collection PubMed
description Heart failure is an increasingly prevalent condition resulting in recurrent hospitalisations and significant mortality and morbidity. The management of heart failure has evolved, and multiple drugs have an established mortality benefit in heart failure with reduced ejection fraction. Although the focus should be on ensuring that patients are treated with the maximum tolerated doses of these guideline-directed therapies, diuretics continue to play a key role in the management of clinical congestion in all forms of heart failure. Clinicians play a key role in heart failure management. Familiarity with the role of diuretics and their dosing and monitoring is critical.
format Online
Article
Text
id pubmed-9722345
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-97223452022-12-06 Diuretics in the management of chronic heart failure: when and how Magdy, Joseph S McVeigh, James Indraratna, Praveen Aust Prescr Article Heart failure is an increasingly prevalent condition resulting in recurrent hospitalisations and significant mortality and morbidity. The management of heart failure has evolved, and multiple drugs have an established mortality benefit in heart failure with reduced ejection fraction. Although the focus should be on ensuring that patients are treated with the maximum tolerated doses of these guideline-directed therapies, diuretics continue to play a key role in the management of clinical congestion in all forms of heart failure. Clinicians play a key role in heart failure management. Familiarity with the role of diuretics and their dosing and monitoring is critical. NPS MedicineWise 2022-11-30 2022-12 /pmc/articles/PMC9722345/ /pubmed/36479331 http://dx.doi.org/10.18773/austprescr.2022.069 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Article
Magdy, Joseph S
McVeigh, James
Indraratna, Praveen
Diuretics in the management of chronic heart failure: when and how
title Diuretics in the management of chronic heart failure: when and how
title_full Diuretics in the management of chronic heart failure: when and how
title_fullStr Diuretics in the management of chronic heart failure: when and how
title_full_unstemmed Diuretics in the management of chronic heart failure: when and how
title_short Diuretics in the management of chronic heart failure: when and how
title_sort diuretics in the management of chronic heart failure: when and how
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722345/
https://www.ncbi.nlm.nih.gov/pubmed/36479331
http://dx.doi.org/10.18773/austprescr.2022.069
work_keys_str_mv AT magdyjosephs diureticsinthemanagementofchronicheartfailurewhenandhow
AT mcveighjames diureticsinthemanagementofchronicheartfailurewhenandhow
AT indraratnapraveen diureticsinthemanagementofchronicheartfailurewhenandhow